Targeting Alpha-Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD-1 Blockade Immunotherapy in Renal Cell Carcinoma.
Li L, Zeng X, Chao Z, Luo J, Guan W, Zhang Q, Ge Y, Wang Y, Xiong Z, Ma S, Zhou Q, Zhang J, Tian J, Horne D, Yuh B, Hu Z, Wei GH, Wang B, Zhang X, Lan P, Wang Z.
Li L, et al. Among authors: zeng x.
Adv Sci (Weinh). 2023 Sep;10(27):e2301975. doi: 10.1002/advs.202301975. Epub 2023 Aug 1.
Adv Sci (Weinh). 2023.
PMID: 37526345
Free PMC article.